4//SEC Filing
Quiroz Jorge Armando 4
Accession 0000899243-18-030087
CIK 0001707502other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:01 PM ET
Size
11.7 KB
Accession
0000899243-18-030087
Insider Transaction Report
Form 4
Quiroz Jorge Armando
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-12-03$29.94/sh−1,200$35,924→ 267,042 total - Sale
Common Stock
2018-12-03$30.21/sh−6,154$185,900→ 260,888 total - Sale
Common Stock
2018-12-03$31.41/sh−31,426$987,147→ 229,462 total - Sale
Common Stock
2018-12-03$32.24/sh−1,370$44,174→ 228,092 total
Footnotes (5)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $29.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $31.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727401
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:01 PM ET
- Size
- 11.7 KB